Renal Insufficiency DPP-4 inhibitors have also been examined in placebo-controlled studies in subjects with type 2 diabetes and chronic renal insufficiency, including patients with end-stage renal disease on dialysis (118121)
Some healthcare providers have more experience prescribing semaglutide due to its longer market presence
Wang, J., Jiang, M., Chen, X
We use cookies to offer you a better experience and analyze our site traffic
If youre already taking medications for HS, such as biologics, you should talk to your doctor about whether adding a GLP-1 drug is safe
Brand-name Mounjaro and Zepbound are manufactured under strict pharmaceutical controls with consistent formulations, concentrations, and delivery devices